Pertussis and influenza immunisation during pregnancy: a landscape review

Bahaa Abu Raya1, Kathryn M Edwards2, David W Scheifele1

  • 1Vaccine Evaluation Center, BC Children's Hospital, Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada.

Insights

Maternal immunisation using tetanus, diphtheria, and acellular pertussis (Tdap) and influenza vaccines offers protection for mothers and infants. Ongoing research is crucial to address remaining knowledge gaps for these important pregnancy vaccines.

Area of Science:

  • Maternal and Child Health
  • Vaccinology
  • Immunology

Background:

  • Maternal immunisation is an emerging strategy primarily involving tetanus, pertussis, and influenza vaccines.
  • These vaccines, though not developed for pregnancy, effectively protect mothers and infants.
  • Increased pertussis and influenza risks in infants have led to recommendations for maternal vaccination.

Purpose of the Study:

  • To review the current evidence for maternal immunisation against pertussis and influenza.
  • To identify existing knowledge gaps regarding the safety and efficacy of these vaccines in pregnancy.
  • To highlight areas for future research in maternal immunisation.

Main Methods:

  • Literature review of scientific evidence supporting maternal immunisation.
  • Analysis of recommendations from various countries regarding pertussis and influenza vaccination during pregnancy.
  • Identification of knowledge gaps based on current scientific understanding.

Main Results:

  • Scientific evidence supporting maternal immunisation against pertussis and influenza is growing.
  • Several countries have adopted universal maternal Tdap vaccination due to infant pertussis concerns.
  • Influenza immunisation in pregnancy is widely recommended to protect mothers and infants.

Conclusions:

  • Maternal immunisation against pertussis and influenza is increasingly supported by scientific evidence.
  • Despite accumulating data, significant knowledge gaps persist.
  • Future research is essential to further inform and optimize maternal immunisation strategies.

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
52.8K
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.0K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.4K
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.8K
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
1.4K
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
2.0K